Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment

Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy

(2020) Yuzhu Hu et al.   International Journal of Nanomedicine

Anti-Glioma Effect with Targeting Therapy Using Folate Modified Nano-Micelles Delivery Curcumin

(2020) Yihong He et al.   Journal of Biomedical Nanotechnology

Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd2O3 nanorods with dual-model imaging and targeted therapy of brain tumor

(2019) Weina Zhang et al.   CHINESE CHEMICAL LETTERS

Ultrasound-Triggered Nanodroplets for Targeted Co-Delivery of Sorafenib/Doxorubicin for Hepatocellular Carcinoma Therapy

(2019) Tan Yang et al.   Journal of Biomedical Nanotechnology

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

(2019) Isabelle Ray-Coquard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chemotherapeutic agents for the treatment of metastatic breast cancer: An update

(2018) Mariam Abotaleb et al.   BIOMEDICINE & PHARMACOTHERAPY

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

(2018) Martin Reck et al.   LUNG CANCER

Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers

(2018) Tongtong Zhang et al.   Acta Pharmaceutica Sinica B

Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κ B and the serine/threonine kinase Akt and is independent of tubulin polymerization.

(2018) Smitha V. Bava et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

pH-Responsive supramolecular micelle based on host-guest interaction of poly(β-amino ester) derivatives and adamantyl-terminated poly(ethylene glycol) for cancer inhibition

(2018) Zhuting Yang et al.   CHINESE CHEMICAL LETTERS

Enhanced uptake and improved anti-tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer

(2018) Yuzhu Hu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel

(2018) Susan Halabi et al.   JOURNAL OF CLINICAL ONCOLOGY

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

(2017) Eric Pujade-Lauraine et al.   LANCET ONCOLOGY

Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer

(2017) Xiaoxiao Liu et al.   Nanomedicine-Nanotechnology Biology and Medicine

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

(2015) Jaime Prat   Journal of Gynecologic Oncology

Ovarian cancer

(2014) Gordon C Jayson et al.   LANCET

Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells

(2014) Aditi Mathur et al.   PLoS One

A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

(2013) Robert M. Wenham et al.   GYNECOLOGIC ONCOLOGY

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

(2013) Athanassios Argiris et al.   JOURNAL OF CLINICAL ONCOLOGY

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

(2013) Hugo E R Ford et al.   LANCET ONCOLOGY

Current development in nanoformulations of docetaxel

(2012) Qi Tan et al.   Expert Opinion on Drug Delivery

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma

(2012) Changyang Gong et al.   Nanoscale

The effects of mixed MPEG–PLA/Pluronic® copolymer micelles on the bioavailability and multidrug resistance of docetaxel

(2010) Chao-Feng Mu et al.   BIOMATERIALS

Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin

(2010) Yi-Dong Yan et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

(2010) David W. Miles et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer

(2010) Payam Zahedi et al.   MOLECULAR PHARMACEUTICS

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice

(2009) Narayanan K. Narayanan et al.   INTERNATIONAL JOURNAL OF CANCER

Preparation of MPEG–PLA nanoparticle for honokiol delivery in vitro

(2009) XiuLing Zheng et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

(2009) Michael A. Bookman et al.   JOURNAL OF CLINICAL ONCOLOGY

Curcumin and cancer: An “old-age” disease with an “age-old” solution

(2008) Preetha Anand et al.   CANCER LETTERS

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

(2008) Bharat B. Aggarwal et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Curcumin as “Curecumin”: From kitchen to clinic

(2007) Ajay Goel et al.   BIOCHEMICAL PHARMACOLOGY